lipoprotein cholesterol and high triglyceride levels in the Mexican population, Mexicans have not been included in any of the previously reported genome-wide association studies for lipids. Methods and Results-We investigated 6 single-nucleotide polymorphisms associated with triglycerides, 7 with high-density lipoprotein cholesterol, and 1 with both triglycerides and high-density lipoprotein cholesterol in recent Caucasian genome-wide association studies in Mexican familial combined hyperlipidemia families and hypertriglyceridemia case-control study samples. These variants were within or near the genes ABCA1, ANGPTL3, APOA5, APOB, CETP, GALNT2, GCKR, LCAT, LIPC, LPL (2), MMAB-MVK, TRIB1, and XKR6-AMAC1L2. We performed a combined analysis of the family-based and case-control studies (nϭ2298) using the Z method to combine statistics. Ten of the single-nucleotide polymorphisms were nominally significant and 5 were significant after Bonferroni correction (Pϭ2.20ϫ10 Ϫ3 to 2.6ϫ10 Ϫ11 ) for the number of tests performed (APOA5, CETP, GCKR, and GALNT2). Interestingly, our strongest signal was obtained for triglycerides with the minor allele of rs964184 (Pϭ2.6ϫ10 Ϫ11 ) in the APOA1/C3/A4/A5 gene cluster region that is significantly more common in Mexicans (27%) than in whites (12%). Conclusions-It is important to confirm whether known loci have a consistent effect across ethnic groups. We show replication of 5 Caucasian genome-wide association studies lipid associations in Mexicans. The remaining loci will require a comprehensive investigation to exclude or verify their significance in Mexicans. We also demonstrate that rs964184 has a large effect (odds ratio, 1.74) and is more frequent in the Mexican population, and thus it may contribute to the high predisposition to dyslipidemias in Mexicans. (Circ Cardiovasc Genet. 2010;3:31-38.)
MVK, PLTP, and TTC39B) and 12 loci with TGs (ANGPTL3, APOA1/C3/A4/A5 gene cluster, APOB, FADS1/2/3, GCKR, LPL, MLXIPL, NCAN-CILP2-PBX4, PLTP, APOE, TRIB1, and XKR6-AMAC1L2). However, whether these variants also confer risk in populations with a different demographic history, such as Mexicans, remains unexplored. Thus, we examine whether these known risk variants are involved in the increased susceptibility to dyslipidemia in Mexicans.
Because only a small fraction of the common variants (Ͼ10 million) are directly or indirectly (imputed) genotyped in current GWAS, these lipid-associated SNPs might not represent the actual functional variants but rather be in linkage disequilibrium (LD) with the causal variants. As patterns of LD vary between populations, 8 studies in Mexicans can also assist in fine mapping the actual susceptibility variants. Furthermore, it is necessary to establish whether confirmed loci have a consistent effect across ethnic groups if they are to be used in cardiovascular risk assessment. 9 In this study, we investigated common variants in Mexicans (minor allele frequency Ͼ10%) within or near the genes ABCA1, ANGPTL3, APOA1/C3/A4/A5 gene cluster, APOB, CETP, GALNT2, GCKR, LCAT, LIPC, LPL, MMAB-MVK, TRIB1, and XKR6-AMAC1L2. Seven of these genes were previously known to be involved in lipid metabolism: ATPbinding cassette A1 (ABCA1), necessary for the efflux of cholesterol from cells to HDL particles; apolipoproteins (APOA1/C3/A4/A5 and B), the structural components and ligands of lipoprotein particles; lecithin-cholesterol acyltransferase (LCAT) that catalyzes the formation of cholesteryl esters in HDL particles; cholesterylester transfer protein (CETP) that transfers cholesteryl esters from HDL particles to apo-B containing lipoproteins in exchange for TGs; and the lipases, hepatic lipase (LIPC) and lipoprotein lipase (LPL), that hydrolyze TGs on lipoproteins. 10 Of the remaining 6 genes, the function of TRIB1 and XKR6-AMAC1L2 is poorly understood. The angiopoietinlike protein 3 (ANGPTL3) is a secreted protein that inhibits LPL activity posttranscriptionally. 11 GALNT2 encodes the polypeptide N-acetylgalactosaminyltransferase 2, involved in the first step of O-linked glycosylation of proteins. GALNT2 may thus affect HDL-C through the glycosylation of proteins involved in lipid metabolism. For instance, LCAT, apoC-III, very low-density lipoprotein, and low-density lipoprotein receptors are all O-glycosylated. 12 The glucokinase regulatory protein (GCKR) regulates glucokinase (GCK), a key regulator of glucose storage and disposal in the liver. 13 MVK and MMAB are both regulated by the sterol-responsive element-binding protein 2 (SREBP2) through a shared common promoter. 12 SREBP2 is a transcription factor that controls cholesterol homeostasis. MVK encodes the mevalonate kinase, which catalyzes an early step in the biosynthesis of cholesterol. 12 Methylmalonic aciduria (MMAB) encodes an enzyme involved in the formation of adenosylcobalamin, necessary for degradation of cholesterol. 12 However, the exact mechanisms by which these novel genes influence HDL and/or TG metabolism remain to be clarified in future studies.
We investigated these GWAS loci in 2 independent Mexican dyslipidemic study samples comprised a hypertriglyceridemia case-control sample and families with familial com-bined hyperlipidemia (FCHL [Mendelian Inheritance in Man 144250]). FCHL is a common genetic dyslipidemia affecting 1% to 6% of the general population and 10% to 20% of subjects with premature coronary artery disease. 14, 15 FCHL is primarily characterized by elevated levels of serum TGs, total cholesterol or both, 16 -18 with additional component traits including low HDL-C levels. 19 As all GWAS for lipids to date examined study samples that were not ascertained for dyslipidemia, this is also the first study to investigate these variants in dyslipidemic study samples at increased risk to develop coronary artery disease.
Methods

Study Participants
The study design was approved by the ethics committees of the participating centers. All subjects provided a written informed consent. Clinical characteristics of the study samples are shown in supplemental Table I. A total of 73 extended Mexican FCHL families (nϭ877) were included in this study. The families were recruited at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán in Mexico City, as described previously. 20 None of the family members were using lipid-lowering medication when the blood sample was taken. The 1421 hypertriglyceridemic cases (nϭ727) and controls (nϭ694) were also recruited at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán in Mexico City. The inclusion criteria were fasting serum TGs Ͼ2.3 mmol/L (200 mg/dL) for the cases and Ͻ1.7 mmol/L (150 mg/dL) for the controls. 21 Exclusion criteria were type 2 diabetes mellitus or morbid obesity (body mass index Ͼ40 kg/m 2 ), and the use of lipid-lowering drugs for the controls. The case-control samples were also classified as low HDL-C if serum HDL-C levels were Ͻ1.04 mmol/L (40 mg/dL; nϭ480) and normal HDL-C if serum HDL-C levels were Ն1.3 mmol/L (50 mg/dL; nϭ492). 21 Measurements of fasting TG and HDL-C levels were performed with commercially available standardized methods in both the families and case-control study samples. 20
SNP Selection and Genotyping
Sixteen SNPs surpassing genome-wide significant threshold 22 (PϽ5ϫ10 Ϫ8 ) for either HDL-C or TGs in Caucasian GWAS [5] [6] [7] and with minor allele frequency Ն0.1 based on the HapMap 23 Mexican-American data were genotyped using the SNPlex genotyping platform (Applied Biosystems). These variants were within or near the genes ABCA1, ANGPTL3, ANGPTL4, APOA5, APOB, CETP, GALNT2, GCKR, LCAT, LIPC, LPL (2), MMAB-MVK, PLTP, TRIB1, and XKR6-AMAC1L2 (supplemental Table II ). Two of the SNPs, rs2967605 near ANGPTL4 and rs7679 near PLTP, had Ͻ90% genotype call rate and were excluded from subsequent analyses. All other SNPs had at least 90% genotype call rate and were in Hardy-Weinberg equilibrium (PϾ0.05) in the normotriglyceridemic controls, as well as in 171 unrelated FCHL family members. Only 1.35 Mendelian errors per SNP were found in 451 genotyped parent-offspring pairs (overall error rate, 0.003) with the PEDSTATS program, 24 and these were excluded from subsequent analyses.
Statistical Analyses
The case-control subjects were analyzed by logistic regression analysis for the additive model, as implemented in the PLINK version 1.06 software. 25 In the Mexican FCHL sample, quantitative lipid levels were used to use data from all available family members. Association analysis was performed using the quantitative transmission disequilibrium test (QTDT) implemented in the genetic analysis package SOLAR 26, 27 using an additive model with age and sex as covariates. TG values were log transformed to approach a normal distribution. Furthermore, the t distribution rather than the normal distribution option of SOLAR was used to allow for robust estima-tion of the mean and variance even if the trait distribution deviates from normality. 28 We did not use a joint analysis with pooled genotype data of the families and case-control samples because different ascertainment procedures were used to collect these study samples. Accordingly, the case-control sample was analyzed using affection status, whereas in the families the entire lipid distribution was used. We then performed a combined analysis of the family-based and case-control studies (nϭ2298) using the Z-method to combine statistics. 29, 30 The Z-statistics were summed and weighted by the square root of the proportion of individuals examined in each study. 30 Genotype data for the GWAS-associated SNPs were extracted from the International HapMap Project 23 (http://www.hapmap.org) Phase 3 dataset for CEU [Northern and Western European ancestry from the Centre d'Etude du Polymorphisme Humain (CEPH) collection] and MEX (Mexican ancestry from Los Angeles, Calif). Only genotypes of founders were used for the estimation of allele frequencies, and accordingly 112 founders of European ancestry and 50 founders of Mexican ancestry were included in the analyses. Differences in allele frequencies between the Mexican American and CEU founders of HapMap were determined by a 2 test. We also compared the allele frequencies of the 112 CEU founders of HapMap with 150 of the Mexican controls from Mexico city (TGs Ͻ150 mg/dL and HDL-C Ͼ50 mg/dL) using a 2 test.
Genotype data in the surrounding regions of the GWAS-associated SNPs (Ϯ100 kb) were extracted from HapMap in similar manner. Only SNPs having frequencies in both populations were included (130 SNPs per region on average), and only genotypes of founders were used in the LD analysis. LD was measured in r 2 using the "matrix" option of the PLINK version 1.05 software.
We estimated the proportion of cases and controls exceeding the clinical thresholds 21 for low HDL-C (Ͻ40 mg/dL) and high TGs (Ͼ200 mg/dL) as a function of the allelic dosage score for HDL-C and TGs, respectively. 5 Allelic dosage scores were calculated for SNPs associated with probability value Յ0.01 (Table 1 and supplemental Table II ) by weighting the counts of the risk allele (0, 1, or 2) by the ␤ coefficient of the logistic-regression model (log odds ratio) and summing across all SNPs. 5 We performed a test of trend across the genotype scores using the "prop.trend.test" function in R (version 2.8.0).
Results
We tested whether 15 SNPs surpassing genome-wide significant threshold 22 for either HDL-C or TGs in Caucasian GWAS [5] [6] [7] are associated in Mexicans. Each variant was tested for association with HDL-C or TGs based on the Caucasian GWAS genome-wide significant results. Accordingly, 8 SNPs were analyzed for HDL-C and 7 for TGs (rs964184 near the APOA5 was analyzed with both HDL-C and TGs). We considered the attempts to replicate variants identified for HDL-C and TGs as separate experiments, and therefore we adjusted the HDL-C association results for 8 independent tests and TGs for 7 independent tests based on the number of variants analyzed for each trait.
Three SNPs were associated with HDL-C after Bonferroni correction for 8 independent tests (Bonferroni significant level Pϭ6.25ϫ10 Ϫ3 ): rs3764261 residing 2.5 kb upstream of CETP (Pϭ2.35ϫ10 Ϫ8 ), rs964184 11 kb upstream of APOA5 (Pϭ1.06ϫ10 Ϫ3 ), and rs4846914 in the first intron of GALNT2 (Pϭ2.20ϫ10 Ϫ3 ). Two SNPs were significant with TGs after Bonferroni correction for 7 independent tests (Bonferroni significant level Pϭ7.14ϫ10 Ϫ3 ): rs964184 residing near APOA5 (Pϭ2.60ϫ10 Ϫ11 ) and rs1260326 a missense variant in GCKR (Pϭ1.26ϫ10 Ϫ3 ). These signals were all for the same risk allele as in whites (Table 1) . †Z score of the minor allele for low HDL-C or high TGs.
‡MAF indicates the minor allele frequency in controls/cases of the corresponding trait. §OR (95% CI) indicates the odds ratio and 95% confidence interval. ʈRisk allele indicates the allele that is associated with unfavorable lipid outcome (low HDL-C or high TGs) in Europeans [5] [6] [7] and Mexicans. ¶The SNP rs3764261, which is in perfect LD (r 2 ϭ 1) with rs173539 in the HapMap CEU data, was genotyped instead of rs173539.
Evaluation of Global Ancestry With the GWAS Variants and Lipid Traits
Mexicans are an admixed population, descended from a recent mix of Amerindian and European ancestry with a small proportion of African ancestry. 31, 32 Population admixture may confound allelic association if both the trait distribution and the allele frequency differ between ancestries. Familybased association has the advantage that it is robust to spurious associations due to population admixture. 33 However, to minimize the possibility of spurious associations due to admixture in the case-control study sample, we evaluated whether the trait distributions and/or the effect of the GWAS variants differs with ancestry estimates in 588 Mexican family members for which we had individual ancestry (IA) estimates available (supplemental Methods). As both the FCHL families and the hypertriglyceridemic cases and controls were recruited by the same dyslipidemia clinic, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, in Mexico City, we anticipated that the proportion of ancestry admixture in the families would also be representative of the cases and controls. To investigate the relationship between the GWAS variants and ancestry, we examined the effect of genotype x ancestry interaction on the traits by inclusion of the genotypes, coded as 0 to 2 copies of the minor allele, IAs, and their interaction term in the model (supplemental Methods). 34 We did not observe a significant interaction between the genotype and individual ancestry on HDL-C levels with any of the 8 HDL-C SNPs (PϾ0.06) or on TGs with any of the 7 TG SNPs (PϾ0.09; supplemental Table II and Figure I ). The nonsignificant interaction results suggest that the strength of association is not different between the ancestry backgrounds, and hence ethnic admixture should not influence the strength of the association with these SNPs even when using a nonfamily-based robust approach. Similarly, neither HDL-C nor TG levels were significantly associated with ancestry in the Mexican families (PϾ0.6; supplemental Figure I ). Furthermore, to ensure that FCHL is not significantly associated with ancestry, we also examined the relation between the individual ancestry proportions and total cholesterol levels, which was also used to define the FCHL families. As for TGs, total cholesterol levels were also not significantly associated with individual ancestry (Pϭ0.4; supplemental Figure I ). Taken together, these data show that the associations and the distribution of lipid traits are not influenced by ancestry in Mexican families, suggesting that admixed ancestry should not influence our association analyses in the unrelated study sample.
Evaluation of the GWAS Allele Frequencies in Europeans and Mexicans
The contribution of a variant to disease susceptibility in a population depends on its frequency. Hence, we evaluated whether the allele frequencies of the variants differ between Europeans and Mexicans by comparing the genotype data of 112 CEU founders with European ancestry from the HapMap project 23 with 150 of the Mexican controls (TGs Ͻ150 mg/dL and HDL-C Ͼ50 mg/dL; Table 2 ). Interestingly, our strongest association signal (Pϭ2.60ϫ10 Ϫ11 ; Table 1 ) was obtained with TGs for the minor allele of rs964184 near the APOA1/C3/A4/A5 gene cluster that is significantly more common in Mexicans (27%) than in Europeans (12%; Pϭ5.89ϫ10 Ϫ5 ; Table 2 ). Similarly, the common allele of rs10468017 near LIPC, that was nominally significant with HDL-C (Pϭ9.19ϫ10 Ϫ3 ; supplemental Table II) , is also more prevalent in Mexicans (81%) than in Europeans (69%; Pϭ1.74ϫ10 Ϫ3 ; Table 2 ). Conversely, the frequency of the risk allele of rs7819412 near XKR6-AMAC1L2 that did not replicate in this study was significantly less frequent in Mexicans than Europeans (27% versus 51%, Pϭ1.04ϫ10 Ϫ8 ; Table 2 ).
Because the allele frequencies of the Mexican controls might not represent the frequencies in the general population, as is the case for the HapMap samples, we also performed this analysis by comparing the genotype data of the European CEU founders with 50 Mexican American founders from the HapMap project who identified themselves as having grandparents who were born in Mexico. The results of the 2 analyses were in good agreement ( Table 2 ) except for rs1883025 near ABCA1 that is significantly more frequent in the HapMap Mexican American sample when compared with the European CEU founders but not with the Mexican controls from Mexico City ( Table 2 ).
Comparison of LD in the Surrounding Regions of the GWAS Variants Between the European and the Mexican Populations
The function of most variants identified in GWAS is unknown, and most of these variants reside outside coding regions. 35 Hence, these SNPs might not represent the actual susceptibility variants but rather be in LD (ie, tag) with the functional variants. Studies in Mexicans also offer the opportunity to examine the surrounding LD of the associated alleles and assist in fine mapping of the actual susceptibility variant, because LD patterns in the area of the associated variants is likely to be different in diverse populations. Therefore, we evaluated whether the LD structures surrounding the Caucasian GWAS variants differ in the Mexican population. We examined the pairwise LD of each variant with its neighboring SNPs (Ϯ100 kb) in the Mexican and European populations using the HapMap data. For each variant, we compared the concordance of SNPs they tagged with r 2 Ն0.7 in Mexicans relative with Europeans. We observed differences in tagging for 5 of the GWAS variants in Mexicans (rs10096633, rs2083637, rs7819412, rs4846914, and rs1883025) because these 5 SNPs tagged less SNPs in Mexicans than in whites (supplemental Figure II) , suggesting that Mexicans may be informative in fine mapping studies of these GWAS loci (LPL [2] , XKR6-AMAC1L2, GALNT2, and ABCA1]). However, overall, the percentage of agreement was high (78% on average), with the least agreement obtained for rs10096633 downstream of LPL (20%; supplemental Figure II) . Interestingly, also the association signals (10 tests with PϽ0.05) were all for the same risk allele as in whites 5-7 except for rs10096633 that was nominally significant with TGs (Pϭ8.08ϫ10 Ϫ3 ) for the opposite allele as in whites (supplemental Table II ). Hence, this observed difference in the pairwise LD may explain the allelic discrepancy of rs10096633 between Mexicans and Europeans.
Proportion of Individuals With Low HDL-C or High TGs as a Function of an Allelic Dosage Score
Because plasma HDL-C and TGs levels are polygenic traits, we also examined the cumulative effect of the associated risk alleles ("allelic dosage") on the proportion of individuals exceeding clinical thresholds for low HDL-C (Ͻ40 mg/dL) and high TG (Ͼ200 mg/dL). 21 We calculated allelic dosage scores in the hypertriglyceridemic cases and controls for SNPs associated with P value Յ0.01 (Table 1 and supplemental Table II ) Accordingly, SNPs near CETP, APOA5, GALNT2, and LIPC were included in the low HDL-C analysis and SNPs near APOA5, GCKR, and LPL in the high TG analysis. The proportion of individuals exceeding clinical thresholds for low HDL-C and high TG levels increased with the genotype score (Figure) . To evaluate the incline in proportions, we also performed a test of trend across the genotype scores. The trends were statistically significant for both the low HDL-C (Pϭ1.89ϫ10 Ϫ8 ) and the high TG proportions (Pϭ5.07ϫ10 Ϫ13 ).
Discussion
Hispanic populations, such as Mexicans, have been mainly ignored in large-scale genetic studies for cardiovascular risk factors and other common diseases, although the Mexican population has an increased predisposition to several forms of dyslipidemias (low HDL-C and high TGs) and premature coronary artery disease. [2] [3] [4] This study evaluated whether 15 associations identified in recent Caucasian GWAS 5-7 with HDL-C or TGs also confer risk in the Mexican population. Association at nominal level (PՅ0.05) was observed for 10 of the loci, of which half were also significant after adjusting for multiple comparisons. Importantly, we also demonstrate
The proportion of cases and controls exceeding the clinical thresholds based on the NCEP: ATPIII criteria 21 for low HDL-C (Ͻ40 mg/dL) and high TGs (Ͼ200 mg/dL) as a function of the allelic dosage score for HDL-C and TGs, respectively. 5 Allelic dosage scores are plotted on the x axis, and the proportion of individuals with low HDL-C (left) and high TGs (right) on the y axis. We modeled 4 alleles for low HDL-C and 3 for high TGs, associated at Ͻ0.01 level (supplemental Table II ). The dashed line indicates the expected proportions given the number of cases and controls. Both trends were highly significant (PϽ1.89ϫ10 Ϫ8 ). that 2 associated SNPs are more prevalent in the Mexican population, and thus may confer to the increased predisposition to these forms of dyslipidemia in Mexicans.
Mexicans descend from a recent mix of Amerindian and European ancestry, which led to marked differences in allelic frequencies and patterns of LD across their genome. 31, 32 Our strongest association signal (Pϭ2.60ϫ10 Ϫ11 ) was obtained for the minor allele of rs964184 near the APOA1/C3/A4/A5 cluster that is significantly more prevalent in Mexicans (27%) than in whites (12%). The strength of this association even surpassed the stringent criteria for declaring genome-wide significance 22 (PϽ5ϫ10 Ϫ8 ) with only 2298 individuals studied. This finding clearly demonstrates that even if a variant has an effect in all ancestry groups, it might be more prevalent in one population. Furthermore, this finding suggests that depending on its frequency, the contribution of each locus to disease susceptibility may vary between populations, and hence the implications of SNPs to public health can differ between populations.
The association signals (PՅ0.05) were all for the same risk allele as in whites 5-7 except for rs10096633, downstream of the LPL gene, that was significant for the opposite allele as in whites. 6 Although the allele frequency of rs10096633 was not significantly different between Mexicans and Europeans (Pϭ0.8), we show that the LD structure surrounding rs10096633 varies between the 2 populations. This finding suggests that rs10096633 is not the causal variant and that given the altered LD, future studies in Mexicans could assist in fine mapping the actual functional variant in this locus. Conversely, SNP rs964184 near the APOA1/C3/A4/A5 gene cluster may be the actual susceptibility variant, because in both populations, this SNP is a singleton (all pairwise r 2 Ͻ0.7) and strongly associated with TGs despite the large difference in allele frequency. Nevertheless, deep resequencing in the rs964184 region is needed to conclude that this SNP is the sole signal.
Although the genes of the APOA1/C3/A4/A5 cluster (Ն11 kb away) are the most plausible candidates in the region of rs964184, this variant resides in the 5Ј UTR of a zinc finger protein (ZPR1) that may be involved in cell proliferation and signal transduction. 36 Hence, functional studies are warranted to establish the actual causal gene and the consequences of this variant. Regarding the other significant (ie, Bonferroni correction) variants, SNP rs4846914 resides in the first intron of GALNT2. There are several SNPs redundant to rs4846914 (r 2 Ն0.7), all located within the first intron. First introns are known to harbor many regulatory elements. 37 Accordingly, all of these variants in LD should be tested for potential regulatory effect. Similarly, rs3764261 resides 2.5 kb upstream of CETP. This SNP is in high LD with variants located 1 to 8 kb from the transcriptional start site of CETP. Thus, these variants and their haplotypes should also be investigated in functional studies. On the other hand, SNP rs1260326 is a missense variant (P446L) in GCKR, and recent in vitro experiments have shown that this amino acid substitution affects glucose and TG levels through increased GCK activity in the liver. 13 To screen for association signals, we also used familybased association method that is robust to population admix-ture, 33 such as in Mexicans. 31, 32 Furthermore, we examined whether the associations were influenced by global ancestry using European/Amerindian informative markers. To reduce sources of heterogeneity, both the dyslipidemic families and case-control study samples were recruited by the same dyslipidemia clinic. We recognize that differences in ascertainment criteria may have potentially caused heterogeneity. For instance, the common allele of rs2083637 near the LPL gene was associated with HDL-C (Pϭ3.85ϫ10 Ϫ3 ) in the case-control samples, as in whites, 7 whereas the opposite allele was implicated in the FCHL families (Pϭ2.65ϫ10 Ϫ2 ), suggesting that a different variants in LPL may be involved in FCHL. 38 Nevertheless, we feel that a more reliable conformation was obtained by using a variety of resources that includes dyslipidemic families with multiple affected individuals and unrelated hypertriglyceridemic case-control individuals.
As our sample size was not sufficiently powered for rare variants and small genetic effects (odds ratioϽ1.3), we have not attempted to investigate confirmed associations with minor allele frequency Ͻ10% in the Mexican-American data of HapMap. Hence, given our relatively small sample size, the remaining loci and those that did not replicate in this study will require comprehensive investigation using larger samples to exclude or verify their significance in Mexicans. Future GWAS in Mexicans should further assist in fine mapping the causal variants in these known loci and reveal novel susceptibility alleles.
In summary, this is the first study to present association signals of susceptibility variants from Caucasian GWAS for lipids in Mexicans. Furthermore, thus far, all GWAS for lipids have examined study samples that were not ascertained for dyslipidemia. Hence, to the best of our knowledge, this is also the first study to report the effect of these variants in dyslipidemic individuals.
